Search - tctmd.com

Displaying 401 - 420 of 788

Sort: Relevancy | Date

News Daily News

El SLF Nobori es Similar al Promus Element en el Manejo de Lesiones Largas

Jason Kahn

May 30, 2014

News Conference News EuroPCR 2014

Nobori BES Demonstrates Good Long-term Outcomes with No Stent Thrombosis Beyond 3 Years

Yael L. Maxwell

May 23, 2014

News Industry News

Data on Angiox (Bivalirudin Injection) in Heart Attack Patients Presented at EuroPCR and Published in European Heart Journal

May 22, 2014

News Conference News EuroPCR 2014

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

Caitlin E. Cox

May 20, 2014

News Industry News

Micell Technologies Announces Clinical Data from MiStent SES Studies Will Be Presented at EuroPCR 2014

May 15, 2014

News Daily News

Cardiac Stress Imaging at 5 Years Post-PCI Holds Prognostic Value

Caitlin E. Cox

May 14, 2014

News Daily News

Coronary Microvascular Dysfunction Common in Both Sexes, Predicts MACE

May 07, 2014

News Daily News

British Registry: Prehospital ECG Associated with Reduced Mortality in ACS Patients

L.A. McKeown

April 18, 2014

News Daily News

Patients with Cardiac Arrest Fare Poorly After PCI

April 17, 2014

News Daily News

PLATO Analysis: No Sex-Based Difference in Ticagrelor’s Safety and Efficacy

April 16, 2014

News Daily News

Cardiac Rehab Reduces Late Lumen Loss, Improves Risk Profile in Patients with Long Lesions

April 14, 2014

News Daily News

El Antidiabético Aleglitazar No Logra Reducir los Resultados Isquémicos de Diabéticos con SCA de Reciente Aparición

L.A. McKeown

April 11, 2014

News Daily News

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

L.A. McKeown

April 11, 2014

News Daily News

Remote Postconditioning Fails to Reduce Myocardial Injury in Non-urgent PCI Patients

April 09, 2014

News Conference News ACC 2014

NEXT at 2 Years: Nobori DES Still Noninferior to Xience/Promus

Jason Kahn

March 31, 2014

News Conference News ACC 2014

Intramyocardial Injection of Stem Cells Shows Promise for Severe Ischemic Heart Failure

Yael L. Maxwell

March 31, 2014

News Conference News ACC 2014

Massachusetts Study Sees Steep Declines in Revascularization Over Last Decade

L.A. McKeown

March 30, 2014

News Conference News ACC 2014

High-sensitivity Troponin Testing May Prevent Unnecessary Admissions for Chest Pain

L.A. McKeown

March 30, 2014

News Industry News

Takeda Presents Additional Data from the EXAMINE Cardiovascular Safety Outcomes Trial at the American College of Cardiology's 63rd Annual Scientific Session

March 27, 2014

News Daily News

Most Nonculprit Lesions with Plaque Rupture Do not Lead to Increased Events

March 13, 2014

Advertisement

El SLF Nobori es Similar al Promus Element en el Manejo de Lesiones Largas

Nobori BES Demonstrates Good Long-term Outcomes with No Stent Thrombosis Beyond 3 Years

Data on Angiox (Bivalirudin Injection) in Heart Attack Patients Presented at EuroPCR and Published in European Heart Journal

CENTURY II: Bioresorbable Polymer DES Stands up to Everolimus-Eluting Device

Micell Technologies Announces Clinical Data from MiStent SES Studies Will Be Presented at EuroPCR 2014

Cardiac Stress Imaging at 5 Years Post-PCI Holds Prognostic Value

Coronary Microvascular Dysfunction Common in Both Sexes, Predicts MACE

British Registry: Prehospital ECG Associated with Reduced Mortality in ACS Patients

Patients with Cardiac Arrest Fare Poorly After PCI

PLATO Analysis: No Sex-Based Difference in Ticagrelor’s Safety and Efficacy

Cardiac Rehab Reduces Late Lumen Loss, Improves Risk Profile in Patients with Long Lesions

El Antidiabético Aleglitazar No Logra Reducir los Resultados Isquémicos de Diabéticos con SCA de Reciente Aparición

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

Remote Postconditioning Fails to Reduce Myocardial Injury in Non-urgent PCI Patients

NEXT at 2 Years: Nobori DES Still Noninferior to Xience/Promus

Intramyocardial Injection of Stem Cells Shows Promise for Severe Ischemic Heart Failure

Massachusetts Study Sees Steep Declines in Revascularization Over Last Decade

High-sensitivity Troponin Testing May Prevent Unnecessary Admissions for Chest Pain

Takeda Presents Additional Data from the EXAMINE Cardiovascular Safety Outcomes Trial at the American College of Cardiology's 63rd Annual Scientific Session

Most Nonculprit Lesions with Plaque Rupture Do not Lead to Increased Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content